MIM
TOI icon

MetLife Investment Management’s The Oncology Institute TOI Stock Holding History

MetLife Investment Management’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.3K Sell
27,790
-12,665
-31% -$38.8K ﹤0.01% 2603
2025
Q4 		$144K Buy
40,455
+18,819
+87% +$69.8K ﹤0.01% 2437
2025
Q3 		$75.5K Sell
21,636
-18,309
-46% -$62.7K ﹤0.01% 2746
2025
Q2 		$81.9K Buy
+39,945
New +$99.9K ﹤0.01% 2639

Other funds holding TOI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MetLife Investment Management's TOI Position: Q1 2026 in Review

MetLife Investment Management reduced its The Oncology Institute (TOI) stake by 31% in Q1 2026, selling an estimated $38.8K and leaving 27,790 shares worth $85.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

MetLife Investment Management first reported a position in TOI in Q2 2025 and has held it in 4 quarters since. The position peaked at $144K in Q4 2025. 115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.

  • MetLife Investment Management held 27,790 shares of The Oncology Institute worth $85.3K as of Q1 2026.
  • MetLife Investment Management sold 12,665 The Oncology Institute shares in Q1 2026, an estimated $38.8K.
  • The Oncology Institute made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2603 holding.
  • MetLife Investment Management first reported a position in The Oncology Institute in Q2 2025 and has held it in 4 quarters since.
  • MetLife Investment Management's The Oncology Institute position peaked at $144K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.